Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 3, 2012, Pages 200-207

  Lin, Shih Ping ^a   Liu, Meei Fang ^a   Lin, Chin Fu ^a   Shi, Zhi Yuan ^a,b  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cloxacillin containing double disc synergy test; Extended spectrum lactamase; Polymerase chain reaction; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE GES; BETA LACTAMASE OXA 1; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; BETA LACTAMASE VEB; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; CLOXACILLIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD SAMPLING; BROTH DILUTION; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISK DIFFUSION; DOUBLE DISC SYNERGY TEST; DRUG BLOOD LEVEL; GENE CLUSTER; GENE EXPRESSION; HOSPITAL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CLOXACILLIN; CLUSTER ANALYSIS; DRUG SYNERGISM; ELECTROPHORESIS, GEL, PULSED-FIELD; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PHENOTYPE; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SENSITIVITY AND SPECIFICITY;

EID: 84861229975     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.11.015     Document Type: Article

References (41)

1. Livermore D.M. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?. Clin Infect Dis 2002, 34:634-640.
2. Weldhagen G.F., Poirel L., Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 2003, 47:2385-2392.
3. Fournier D., Hocquet D., Dehecq B., Cholley P., Plesiat P. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa. J Antimicrob Chemother 2010, 65:364-365.
4. Juan C., Mulet X., Zamorano L., Alberti S., Perez J.L., Oliver A. Detection of the novel extended-spectrum beta-lactamase OXA-161 from a plasmid-located integron in Pseudomonas aeruginosa clinical isolates from Spain. Antimicrob Agents Chemother 2009, 53:5288-5290.
5. Zhao W.H., Hu Z.Q. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol 2010, 36:245-258.
6. Chen H.Y., Yuan M., Livermore D.M. Mechanisms of resistance to beta-lactam antibiotics amongst Pseudomonas aeruginosa isolates collected in the UK in 1993. J Med Microbiol 1995, 43:300-309.
7. Kao C.C., Liu M.F., Lin C.F., Huang Y.C., Liu P.Y., Chang C.W., et al. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. J Microbiol Immunol Infect 2010, 43:180-187.
8. Lee C.H., Su L.H., Li C.C., Chien C.C., Tang Y.F., Liu J.W. Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1. Antimicrob Agents Chemother 2010, 54:5395-5398.
9. Wu U.I., Wang J.L., Chen W.C., Chang S.C., Chen Y.C. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur J Clin Microbiol Infect Dis 2011, 30:33-39.
10. Su P.A., Wu L.T., Cheng K.C., Ko W.C., Chuang Y.C., Yu W.L. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods. J Microbiol Immunol Infect 2010, 43:26-34.
11. Lin C.F., Hsu S.K., Chen C.H., Huang J.R., Lo H.H. Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol 2010, 59:665-671.
12. Yang J.L., Wang J.T., Lauderdale T.L., Chang S.C. Prevalence of extended-spectrum beta-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum beta-lactamase production. J Microbiol Immunol Infect 2009, 42:310-316.
13. Yu W.L., Chuang Y.C., Walther-Rasmussen J. Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 2006, 39:264-277.
14. Yan J.J., Tsai S.H., Chuang C.L., Wu J.J. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan. J Microbiol Immunol Infect 2006, 39:130-134.
15. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard 2006, Clinical and Laboratory Standards Institute, M7-A7. Wayne, PA. 7th ed.
16. De Champs C., Poirel L., Bonnet R., Sirot D., Chanal C., Sirot J., et al. Prospective survey of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolated in a French hospital in 2000. Antimicrob Agents Chemother 2002, 46:3031-3034.
17. Nordmann P., Guibert M. Extended-spectrum beta-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother 1998, 42:128-131.
18. Performance standards for antimicrobial susceptibility testing 2010, Clinical and Laboratory Standards Institute, 20th informational supplement, M100-S20. Wayne, PA.
19. Lee S., Park Y.J., Kim M., Lee H.K., Han K., Kang C.S., et al. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 2005, 56:122-127.
20. Liu P.Y., Shi Z.Y., Lau Y.J., Hu B.S., Shyr J.M., Tsai W.S., et al. Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis. J Clin Microbiol 1996, 34:68-70.
21. Bogaerts P., Bauraing C., Deplano A., Glupczynski Y. Emergence and dissemination of BEL-1-producing Pseudomonas aeruginosa isolates in Belgium. Antimicrob Agents Chemother 2007, 51:1584-1585.
22. Rodriguez-Martinez J.M., Poirel L., Nordmann P. Extended-spectrum cephalosporinases in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009, 53:1766-1771.
23. Shi Z.Y., Liu P.Y., Lau Y.J., Lin Y.H., Hu B.S. Epidemiological typing of isolates from an outbreak of infection with multidrug-resistant Enterobacter cloacae by repetitive extragenic palindromic unit b1-primed PCR and pulsed-field gel electrophoresis. J Clin Microbiol 1996, 34:2784-2790.
24. Carter M.W., Oakton K.J., Warner M., Livermore D.M. Detection of extended-spectrum beta-lactamases in klebsiellae with the Oxoid combination disk method. J Clin Microbiol 2000, 38:4228-4232.
25. Florijn A., Nijssen S., Schmitz F.J., Verhoef J., Fluit A.C. Comparison of E test and double disk diffusion test for detection of extended spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 2002, 21:241-243.
26. Yu W.L., Cheng K.C., Chi C.J., Chen H.E., Chuang Y.C., Wu L.T. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Clin Microbiol Infect 2006, 12:579-582.
27. Livermore D.M., Brown D.F. Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother 2001, 48(suppl. 1):59-64.
28. Tzelepi E., Giakkoupi P., Sofianou D., Loukova V., Kemeroglou A., Tsakris A. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and. Enterobacter aerogenes. J Clin Microbiol 2000, 38:542-546.
29. Jiang X., Zhang Z., Li M., Zhou D., Ruan F., Lu Y. Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2006, 50:2990-2995.
30. Tam V.H., Schilling A.N., LaRocco M.T., Gentry L.O., Lolans K., Quinn J.P., et al. Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa. Clin Microbiol Infect 2007, 13:413-418.
31. Nordmann P., Ronco E., Naas T., Duport C., Michel-Briand Y., Labia R. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1993, 37:962-969.
32. Nordmann P., Naas T. Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamases. Antimicrob Agents Chemother 1994, 38:104-114.
33. Vahaboglu H., Ozturk R., Aygun G., Coskunkan F., Yaman A., Kaygusuz A., et al. Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother 1997, 41:2265-2269.
34. Girlich D., Naas T., Leelaporn A., Poirel L., Fennewald M., Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis 2002, 34:603-611.
35. Dubois V., Poirel L., Marie C., Arpin C., Nordmann P., Quentin C. Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3-Ib/aac6'-Ib' gene cassettes in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002, 46:638-645.
36. Mavroidi A., Tzelepi E., Tsakris A., Miriagou V., Sofianou D., Tzouvelekis L.S. An integron-associated beta-lactamase (IBC-2) from Pseudomonas aeruginosa is a variant of the extended-spectrum beta-lactamase IBC-1. J Antimicrob Chemother 2001, 48:627-630.
37. Poirel L., Weldhagen G.F., De Champs C., Nordmann P. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa. J Antimicrob Chemother 2002, 49:561-565.
38. Glupczynski Y., Bogaerts P., Deplano A., Berhin C., Huang T.D., Van Eldere J., et al. Detection and characterization of class A extended-spectrum-beta-lactamase-producing Pseudomonas aeruginosa isolates in Belgian hospitals. J Antimicrob Chemother 2010, 65:866-871.
39. Yan J.J., Hsueh P.R., Ko W.C., Luh K.T., Tsai S.H., Wu H.M., et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001, 45:2224-2228.
40. Yan J.J., Hsueh P.R., Lu J.J., Chang F.Y., Ko W.C., Wu J.J. Characterization of acquired beta-lactamases and their genetic support in multidrug-resistant Pseudomonas aeruginosa isolates in Taiwan: the prevalence of unusual integrons. J Antimicrob Chemother 2006, 58:530-536.
41. Huang Y.T., Chang S.C., Lauderdale T.L., Yang A.J., Wang J.T. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Diagn Microbiol Infect Dis 2007, 59:211-216.